OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Pharmaceutical Analysis is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Publisher’s Note	122
Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity	117
Editorial Board	114
Automated closed-cell production platform solves dilemma of industrial-scale manufacturing for mesenchymal stromal cell-based therapy	113
Editorial Board	113
Editorial Board	105
Editorial Board	104
Gold nanorod-based engineered nanogels for cascade-amplifying photothermo-enzymatic synergistic therapy	102
Metabolic difference of potentially toxic components from Psoraleae Fructus and Euodiae Fructus in Sishen formula by different compatibilities and physiologies	94
Breaking barriers: MS-BDF tools in the quality control of insect-derived traditional Chinese medicine	94
Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids	92
Analysis of GC × GC fingerprints from medicinal materials using a novel contour detection algorithm: A case of Curcuma wenyujin	84
Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablation	81
Time-specific study on the efficacy of stems and leaves of Arachis hypogaea L. targeting glycine/serine metabolism for insomnia treatment	77
1,8-cineole ameliorates colon injury by downregulating macrophage M1 polarization via inhibiting the HSP90-NLRP3-SGT1 complex	70
Targeted metabolomics reveals the aberrant energy status in diabetic peripheral neuropathy and the neuroprotective mechanism of traditional Chinese medicine JinMaiTong	69
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation	68
Small molecule deoxynyboquinone triggers alkylation and ubiquitination of Keap1 at Cys489 on Kelch domain for Nrf2 activation and inflammatory therapy	67
Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells	66
Deep learning-based drug screening for the discovery of potential therapeutic agents for Alzheimer's disease	66
Rapid authentication of different herbal medicines by heating online extraction electrospray ionization mass spectrometry	65
Exploring the impact of the liver-intestine-brain axis on brain function in non-alcoholic fatty liver disease	62
Recent trends of machine learning applied to multi-source data of medicinal plants	59
Effect of cholesterol on distribution, cell uptake, and protein corona of lipid microspheres at sites of cardiovascular inflammatory injury	55
Targeted screening and profiling of massive components of colistimethate sodium by two-dimensional-liquid chromatography-mass spectrometry based on self-constructed compound database	55

Distinct types of regulated cell death in atherosclerosis	55
Fingerprint-enhanced hierarchical molecular graph neural networks for property prediction	54
Validation of breast cancer as a risk factor for anxiety and depression: Insights from Mendelian randomization analysis	51
Generation of SARS-CoV-2 dual-target candidate inhibitors through 3D equivariant conditional generative neural networks	51
Ultrasensitive quantification of trace amines based on N-phosphorylation labeling chip 2D LC-QQQ/MS	51
Time-course monitoring of in vitro biotransformation reaction via solid-phase microextraction-ambient mass spectrometry approaches	50
Understanding the mechanistic and therapeutic perspectives on cytokines and chemokines in acute high-altitude illness syndromes	50
Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors	49
Apatinib and gamabufotalin co-loaded lipid/Prussian blue nanoparticles for synergistic therapy to gastric cancer with metastasis	48
Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection	47
Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistance	45
Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides	44
Targeted bile acids metabolomics in cholesterol gallbladder polyps and gallstones: From analytical method development towards application to clinical samples	44
Dexamethasone palmitate-loaded sHDL nanodiscs: Enhanced efficacy and safety in allergic conjunctivitis	44
Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the art	43
USP50-mediated NLRP3 deubiquitination enhances NLRP3 inflammasome activation to suppress HCC metastasis	43
Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system	41